The department of clinical neuroscience at the Royal Free Hospital has a pioneering history of ground breaking research and is currently engaged in research into all aspects of Parkinson’s and other movement disorders. Collaborating with other UK and international research teams, these studies are sponsored and funded by Parkinson’s UK, the Medical Research Council and the Economic and Social Research Council. We also work closely with colleagues at UCLH.
A high level of collaboration means that our patients can be offered the opportunity to be involved in new research or try potential new therapies.
Our research pages have a vast array of information and resources, including access to the trust’s research portal and details of who to contact for any general queries about the trust’s research activity.
Parkinson’s research register
We keep a contact register of people who might be interested in hearing about current or future research into Parkinson’s. By joining the register you are not consenting to be in a study, only agreeing for your details to be stored on a secure database, so that in the future we can contact you about research that may be of interest to you or your family.
Fill out our expression of interest form to join the research register.
Working with other organisations and charities
We work closely with Parkinson’s UK and the Gauchers Association to ensure all our studies are patient friendly, easy to participate in and that all information regarding the studies and their progress is disseminated on a regular basis to participants and interested parties.
Royal Free Hospital gets tough on smokers
Today the RFH anaesthesia team is launching a new project to reduce blood loss and blood products required by women… twitter.com/i/web/status/1…
Katie Vangucci, clinical lead for orthopaedic therapies at Barnet and Chase Farm hospitals says the RFL values mean… twitter.com/i/web/status/1…
(1/3) When you walk through our doors, you trust that the staff looking after you or your loved ones are doing the… twitter.com/i/web/status/1…